4//SEC Filing
Baker Mark Robert 4
Accession 0001447348-12-000047
CIK 0000835887other
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 12:07 PM ET
Size
11.5 KB
Accession
0001447348-12-000047
Insider Transaction Report
Form 4
Baker Mark Robert
General Counsel
Transactions
- Purchase
Common Stock
2012-11-28$2.12/sh+300$636→ 155,565 total - Purchase
Common Stock
2012-11-28$2.12/sh+100$212→ 155,665 total - Purchase
Common Stock
2012-11-28$2.13/sh+100$213→ 155,865 total - Purchase
Common Stock
2012-11-28$2.13/sh+1,000$2,130→ 156,865 total - Purchase
Common Stock
2012-11-28$2.14/sh+7$15→ 156,872 total - Purchase
Common Stock
2012-11-28$2.13/sh+100$213→ 155,765 total
Footnotes (1)
- [F1]Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Documents
Issuer
PROGENICS PHARMACEUTICALS INC
CIK 0000835887
Entity typeother
Related Parties
1- filerCIK 0001331438
Filing Metadata
- Form type
- 4
- Filed
- Nov 29, 7:00 PM ET
- Accepted
- Nov 30, 12:07 PM ET
- Size
- 11.5 KB